Abstract
Since the discovery of FMS-like tyrosine kinase-3 (FLT3)-activating mutations as genetic drivers in acute myeloid leukemia (AML), investigators have t......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
